复方甘草酸苷治疗寻常型银屑病的临床观察及药理分析

复方甘草酸苷治疗寻常型银屑病的临床观察及药理分析
黄久遂
【期刊名称】《中国处方药》
【年(卷),期】2014(12)7
【摘要】目的：观察复方甘草酸苷治疗寻常型银屑病的临床疗效及药理分析。

方
法选取2012年～2013年收治的寻常型银屑病患者90例作为研究对象，将患者
随机分为观察组及对照组，各45例。

两组患者均应用维A酸乳膏、糠酸莫米松乳膏、窄谱中波紫外线治疗，其中观察组患者在此基础上加用复方甘草酸苷静脉滴注，总疗程8周，采用银屑病面积与严重性指数（PASI评分）标准对两组患者的治疗效果进行评价。

同时测定患者治疗前后血清IL-17、IL-22、IL-23水平。

结果观察组患者临床总有效率明显高于对照组，差异具有统计学意义（P＜0.05）；治疗后血清IL-17、IL-22、IL-23水平明显降低，与治疗前比较差异具有统计学意义（P
＜0.05）。

结论复方甘草酸苷治疗寻常型银屑病疗效确切，能纠正患者的免疫紊乱状态。

%Objective To investigate clinical observation and pharmacological analysis of glycyrrhizin in treating psoriasis vulgaris.Methods 90 cases of patients with psoriasis vulgaris elected as subjects were randomly divided into observation group and control group(45 cases of each group). All patients were treated with vitamin A acid cream, mometasone furoate cream and narrow-band UVB therapy. And the patients of observation group were treated with glycyrrhizin plus by intravenous infusion. After total course of eight weeks, the psoriasis area and the PASI score standards were used to evaluate the treatment of patients of two groups.
And serum IL-17, IL-22, IL-23 levels of patients of two groups were determined before and after treatment.Results The total effective rate of observation group was significantly higher than that of control group. The difference was statistically significant(P<0.05). After treatment, serum IL-17, IL-22, IL-23 levels were significantly lower those pre-
treatment(P<0.05).Conclusion It reaches a curative treatment for glycyrrhizin in treating psoriasis vulgaris, which correct the patient's immune disorders.
【总页数】2页(P30-31)
【作者】黄久遂
【作者单位】广州市皮肤病防治所，广州 510095
【正文语种】中文
【相关文献】
1.甲氨蝶呤合复方甘草酸苷片治疗寻常型银屑病50例临床观察 [J], 邓坚真
2.复方甘草酸苷联合雷公藤多甙片治疗寻常型银屑病的临床观察 [J], 段艳琼
3.复方甘草酸苷联合阿维A治疗寻常型银屑病患者的临床观察 [J], 董淑英
4.复方甘草酸苷联合窄谱中波紫外线治疗寻常型银屑病临床观察 [J], 聂文忠;刘东艳
5.复方甘草酸苷注射液治疗寻常型银屑病及湿疹皮炎的临床观察 [J], 王巧鱼
因版权原因，仅展示原文概要，查看原文内容请购买。